Total Payments
$59,668
2024 Payments
$1,110
Companies
25
Transactions
120
Medicare Patients
2,212
Medicare Billing
$500,814
Payment Breakdown by Category
Other$29,500 (49.4%)
Consulting$16,455 (27.6%)
Travel$10,214 (17.1%)
Food & Beverage$3,404 (5.7%)
Education$95.03 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,500 | 11 | 49.4% |
| Consulting Fee | $16,455 | 11 | 27.6% |
| Travel and Lodging | $10,214 | 27 | 17.1% |
| Food and Beverage | $3,404 | 68 | 5.7% |
| Education | $95.03 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TESARO, Inc. | $45,328 | 62 | $0 (2019) |
| Stryker Corporation | $10,483 | 13 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,579 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $996.67 | 2 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $460.38 | 7 | $0 (2024) |
| Clovis Oncology, Inc. | $205.08 | 4 | $0 (2022) |
| Biom'Up France SAS | $140.13 | 1 | $0 (2020) |
| Janssen Biotech, Inc. | $60.17 | 3 | $0 (2024) |
| Incyte Corporation | $58.08 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $44.72 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,110 | 17 | GlaxoSmithKline, LLC. ($650.00) |
| 2023 | $2,096 | 9 | AstraZeneca Pharmaceuticals LP ($1,501) |
| 2022 | $392.81 | 8 | Clovis Oncology, Inc. ($116.86) |
| 2020 | $256.14 | 5 | Biom'Up France SAS ($140.13) |
| 2019 | $2,442 | 7 | TESARO, Inc. ($1,800) |
| 2018 | $10,650 | 18 | TESARO, Inc. ($10,625) |
| 2017 | $42,722 | 56 | TESARO, Inc. ($32,903) |
All Payment Transactions
120 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $23.14 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Myriad Genetic Laboratories, Inc. | PRECISETUMOR (Device) | Food and Beverage | In-kind items and services | $60.45 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $59.51 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Oncology | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: ONCOLOGY | ||||||
| 08/18/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $22.16 | General |
| Category: Oncology | ||||||
| 08/06/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: Oncology | ||||||
| 07/22/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: Oncology | ||||||
| 07/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.40 | General |
| 07/09/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $28.78 | General |
| 06/28/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Oncology | ||||||
| 05/07/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Oncology | ||||||
| 05/06/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug), DARZALEX, IMBRUVICA | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Oncology | ||||||
| 01/22/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| Category: ONCOLOGY | ||||||
| 11/29/2023 | Myriad Genetic Laboratories, Inc. | PRECISETUMOR (Device) | Food and Beverage | In-kind items and services | $117.67 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $842.50 | General |
| Category: Oncology | ||||||
| 10/26/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Travel and Lodging | In-kind items and services | $518.53 | General |
| Category: Oncology | ||||||
| 10/26/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Travel and Lodging | In-kind items and services | $140.12 | General |
| Category: Oncology | ||||||
| 10/19/2023 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Consulting Fee | Cash or cash equivalent | $346.67 | General |
| Category: ONCOLOGY | ||||||
| 10/13/2023 | Medtronic, Inc. | LIGASURE (Device) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Vessel Sealing | ||||||
| 03/22/2023 | Myriad Genetic Laboratories, Inc. | PRECISETUMOR (Device) | Food and Beverage | In-kind items and services | $37.96 | General |
| Category: ONCOLOGY | ||||||
| 03/22/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $37.96 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 573 | 2,312 | $676,158 | $153,276 |
| 2022 | 16 | 626 | 1,974 | $596,175 | $143,037 |
| 2021 | 10 | 500 | 1,656 | $320,357 | $97,239 |
| 2020 | 10 | 513 | 2,043 | $377,800 | $107,263 |
Total Patients
2,212
Total Services
7,985
Medicare Billing
$500,814
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 45 | 67 | $321,734 | $76,571 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 388 | $142,784 | $35,981 | 25.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 60 | 60 | $42,540 | $9,630 | 22.6% |
| 86304 | Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | Office | 2023 | 66 | 406 | $51,968 | $8,186 | 15.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 114 | $28,500 | $7,136 | 25.0% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 45 | 67 | $44,019 | $5,936 | 13.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 42 | 342 | $21,888 | $3,519 | 16.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 66 | 376 | $7,520 | $3,142 | 41.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 42 | 322 | $11,592 | $2,435 | 21.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 69 | $1,035 | $235.29 | 22.7% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 12 | 13 | $780.00 | $173.68 | 22.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 62 | $992.00 | $136.40 | 13.8% |
| 83550 | Iron binding capacity | Office | 2023 | 12 | 13 | $455.00 | $111.41 | 24.5% |
| 83540 | Iron level | Office | 2023 | 12 | 13 | $351.00 | $82.42 | 23.5% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2022 | 37 | 56 | $268,912 | $65,688 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 296 | $108,928 | $28,332 | 26.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 64 | 64 | $45,376 | $10,230 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 133 | $33,250 | $8,184 | 24.6% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2022 | 16 | 46 | $7,360 | $7,349 | 99.8% |
| 86304 | Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | Office | 2022 | 66 | 332 | $42,496 | $6,797 | 16.0% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2022 | 39 | 58 | $38,106 | $5,363 | 14.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 27 | 36 | $17,856 | $5,086 | 28.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 44 | 214 | $13,696 | $2,205 | 16.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 48 | 264 | $9,504 | $1,993 | 21.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 70 | 343 | $6,860 | $1,006 | 14.7% |
About Dr. Jonathan Oh, MD
Dr. Jonathan Oh, MD is a Gynecologic Oncology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215978051.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Oh, MD has received a total of $59,668 in payments from pharmaceutical and medical device companies, with $1,110 received in 2024. These payments were reported across 120 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($29,500).
As a Medicare-enrolled provider, Oh has provided services to 2,212 Medicare beneficiaries, totaling 7,985 services with total Medicare billing of $500,814. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Location Dallas, TX
- Active Since 06/10/2006
- Last Updated 10/26/2011
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1215978051
Products in Payments
- ZEJULA (Drug) $44,128
- vitagel (Device) $9,623
- LYNPARZA (Drug) $1,554
- JEMPERLI (Biological) $996.67
- 1588 HD 3 CHIP CAMERA (Device) $581.24
- PRECISETUMOR (Device) $254.04
- Variax (Device) $146.72
- HemoBlast Bellows (Device) $140.13
- PreciseTumor (Device) $108.87
- MYRISK (Device) $97.47
- SPY-PHI SYSTEM (Device) $96.23
- Rubraca (Drug) $88.22
- RYBREVANT (Drug) $45.73
- MONJUVI (Drug) $45.30
- KEYTRUDA (Biological) $44.72
- Vitagel (Device) $36.09
- Lenvima (Drug) $29.60
- VARUBI (Drug) $27.88
- FRUZAQLA (Drug) $26.59
- Onivyde (Drug) $24.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Dallas
David Miller, Md, MD
Gynecologic Oncology — Payments: $195,686
Gynecologic Oncology $195,686
Jayanthi Lea, Md, MD
Gynecologic Oncology — Payments: $15,866
Gynecologic Oncology $15,866
Dr. Bruce Fine, M.d, M.D
Gynecologic Oncology — Payments: $5,961
Gynecologic Oncology $5,961
Dr. Erik Koon, Md, Phd, MD, PHD
Gynecologic Oncology — Payments: $5,474
Gynecologic Oncology $5,474
Alan Munoz, M.d, M.D
Gynecologic Oncology — Payments: $4,466
Gynecologic Oncology $4,466
Laura Divine, M.d, M.D
Gynecologic Oncology — Payments: $3,889
Gynecologic Oncology $3,889